In addition to eleven glycoproteins, the herpes simplex virus type 2 (HSV-2) genome encodes several proteins with potential membrane-spanning segments but no asparagine-linked carbohydrates. One of these is UL45. Fractionation of infected cells showed that HSV-2 UL45 is an integral membrane protein, and analysis of UL45 mutants with potential glycosylation sites showed that it has a type II membrane orientation, the first HSV protein known to have this orientation. Furthermore, it is detectable in infected cells at a time similar to that when glycoproteins gB and gD are detected, consistent with a role in cell-cell fusion, which has previously been found for HSV-1 UL45.
The genomes of herpes simplex virus types 1 and 2 (HSV-1 and -2) encode at least 11 glycoproteins, of which 10 have transmembrane anchor regions. Several additional open reading frames, such as UL45, encode proteins that have potential membrane-spanning segments but that lack consensus sites for the addition of asparagine-linked carbohydrates (N-CHO) (9) . The HSV-1 UL45 protein (UL45-1) has 172 residues and a molecular mass of 18 kDa (11) . It is not required for growth of virus in tissue culture (11) but is required for cell-cell fusion caused by a syncytial variant of HSV-1 (6) . HSV-2 UL45 (UL45-2) is also a 172-residue protein, with 75% sequence identity to UL45-1. It was first identified as a 20-kDa protein by in vitro translation of transcripts from HSV-2-infected cells (10) and more recently was shown to cross-react weakly with an antibody raised against UL45-1 (12). To further characterize UL45-2, we have raised an antibody against a glutathione S-transferase (GST)-UL45-2 fusion protein and have made a UL45-2 expression vector; these reagents were used to study the time course of UL45-2 synthesis in infected cells, its association with membranes, its orientation in the membrane, and its cellular location.
A UL45-2 expression vector (pAC265) was derived from pGR44 (a gift from Gary Hayward), which contains the BamHI A fragment from HSV-2 strain 333. A 1.0-kb SmaI fragment containing the UL45-2 open reading frame was subcloned from pGR44 into pCMV3 (1), next to the human cytomegalovirus immediate-early promoter, to produce pAC265. A plasmid carrying a gene expressing a GST-UL45-2 fusion protein was then derived from pAC265 by amplification of the coding sequence for residues 52 to 121 with Pfu DNA polymerase and primers 5Ј-TGGATCCTCGTGGGGACTCTCG-3Ј and 5Ј-TGGATC CGTTCACCCACCAGTAACC-3Ј (BamHI sites underlined); after digestion with BamHI, this fragment was cloned into the BamHI site of pGEX-4T-3 (Pharmacia), in frame with the GST gene, to produce pAC270. Residues 52 to 121 were chosen in order to avoid hydrophobic sequences that might cause the GST-UL45-2 fusion protein to aggregate.
GST-UL45-2 was expressed in Escherichia coli containing plasmid pAC270, purified from a bacterial lysate with glutathione-Sepharose beads, and used to immunize rabbits (Cocalico Biologicals, Inc., Reamstown, Pa.). The rabbits received an initial inoculation of 100 g, followed by three 50-g booster injections. Two sera, LSU32 and LSU33, were obtained, and preliminary Western blots showed that both reacted with GST, with GST-UL45-2, and with many proteins in uninfected CV1 and COS7 cells (data not shown). To reduce this background, anti-GST antibodies were removed from LSU32 by passage through a column of GST cross-linked to glutathione-Sepharose beads by dimethyl pimelimidate-HCl (2) . Dot blot analysis showed that LSU32 then reacted with GST-UL45-2 but not with GST. To test its reactivity with bona fide UL45-2, cytoplasmic extracts were prepared from CV1 cells infected with HSV-2 and from COS7 cells transfected with pAC265, using Nonidet P-40 (NP-40) and sodium deoxycholate detergents for cell lysis (7) . The extracts were electrophoresed on a sodium dodecyl sulfate (SDS)-polyacrylamide gel (5), transferred to nitrocellulose, and probed with LSU32 followed by 125 I-protein A ( therefore represents a cellular protein with which LSU32 crossreacts.
UL45-1 has been shown to be required for cell-cell fusion (6); however, the protein was not detected in infected cells until 9 h postinfection (p.i.) (12) whereas fusion has been observed as early as 5 h p.i. (8) . Many factors may be responsible for this difference, such as the use of different cell types, virus strains, and multiplicities of infection (MOI). Therefore, the time course of UL45-2 synthesis in infected cells was compared to that of the viral glycoproteins gB-2 and gD-2, which by analogy with their HSV-1 counterparts are probably essential for cell-cell fusion, and also to that of gC-2. Cytoplasmic extracts of CV1 cells infected with HSV-2 at an MOI of 1 PFU per cell were prepared at 0 to 12 h p.i., and Western blots of SDS-polyacrylamide gels were probed with the polyclonal antibodies LSU32 (UL45-2), R90 (gB-2), R46 (gC-2), and R7 (gD-2) (Fig. 2 ). UL45-2 was first detected at 4 h p.i., as was gC-2; gB-2 and gD-2 were easily detectable at 4 h and barely detectable at 2 h. The appearance of UL45-2 at a time comparable to the time of appearance of these glycoproteins is consistent with a role in membrane fusion.
Kyte and Doolittle hydropathy plots of the UL45-1 and UL45-2 amino acid sequences reveal a potential membranespanning sequence between residues 24 and 48. Solubilization of UL45-1 from HSV-1 virions with NP-40 detergent provides further evidence for its association with membranes (12) . To determine if UL45-2 is a membrane protein, CV1 cells were infected with HSV-2 at an MOI of 1 PFU per cell and fractionated at 18 h p.i. The cells were scraped into phosphatebuffered saline, pelleted by low-speed centrifugation, and resuspended in 10 mM Tris-HCl (pH 7.5)-10 mM NaCl-3 mM MgCl 2 (reticulocyte standard buffer [RSB]). After cell lysis by one freeze-thaw cycle and sonication, the lysate was centrifuged at 70,000 ϫ g for 30 min at 4°C to produce a pellet and a soluble fraction. The pellet was resuspended either in 0.1 M Na 2 CO 3 (pH 11.0) (to solubilize peripheral membrane proteins) or in RSB containing NP-40 and sodium deoxycholate (to solubilize peripheral and integral membrane proteins) and then centrifuged again at 70,000 ϫ g for 30 min. The supernatants contained high-pH-soluble or detergent-soluble proteins, respectively. The pellets containing high-pH-insoluble or de-
Time course of UL45-2 synthesis, compared to those of gB-2, gC-2, and gD-2. CV1 cells were infected with HSV-2 at an MOI of 1 PFU per cell. Cytoplasmic extracts were prepared at 2-h intervals from 0 to 12 h p.i., electrophoresed on denaturing polyacrylamide gels, transferred to nitrocellulose, and probed with LSU32 (UL45-2), R90 (gB-2), R46 (gC-2), or R7 (gD-2) and then with 125 I-protein A.
FIG. 3.
Membrane association of UL45-2. CV1 cells were infected with HSV-2 for 18 h and then fractionated as described in the text. All fractions were electrophoresed on a denaturing gel, transferred to nitrocellulose, and probed with LSU32 and then with 125 I-protein A.
tergent-insoluble proteins were resuspended in SDS-polyacrylamide gel electrophoresis sample buffer. As a control, a cytoplasmic extract of unfractionated cells was prepared by detergent lysis. All fractions were electrophoresed, transferred to nitrocellulose, and probed with LSU32 (Fig. 3) . As before, UL45-2 was present in the cytoplasmic extract (lane 1); it was also present in the detergent-soluble fraction (lane 3) and the high-pH-insoluble fraction (lane 6) but not in the soluble fraction (lane 2) or detergent-insoluble (lane 4) and high-pHsoluble (lane 5) fractions. UL45-2 is therefore an integral membrane protein.
UL45-1 and -2 have only one region sufficiently hydrophobic to span a membrane, so this region presumably acts as a signal sequence and as a membrane anchor. Since neither protein has a consensus site for the addition of N-CHO, their orientation in the membrane was not obvious. The approach taken to determine the orientation of UL45-2 was one that has frequently been used to study membrane topology, i.e., the creation of potential glycosylation sites on either side of the transmembrane anchor (3, 4) . Mutagenesis to create consensus N-CHO sites was performed by the QuikChange procedure (Stratagene) with Pfu DNA polymerase and using plasmid pAC265 as the template. The primers for changing residue 4 from Arg to Asn were 5Ј-GTCCCGAAGCATTGAAAGCCATAGCAC-3Ј and 5Ј-GTGCTATGGCTTTCAATGCTTCGGGAC-3Ј. The primers for changing residue 111 from Glu to Asn were 5Ј-AA CCCGACGATCTGTTCGCCTGGACGCGTG-3Ј and 5Ј-CA CGCGTCCAGGCGAACAGATCGTCGGGTT-3Ј. The amplification conditions were one cycle of 98°C for 1 min followed by 16 cycles of 98°C for 1 min, 70°C for 1 min 20 s, and 75°C for 12 min. The reaction mix was then incubated with DpnI for 90 min to nick template DNA, followed by transformation of XL1-Blue E. coli. Colonies carrying genes with the desired mutations were identified by DNA sequencing. Plasmid pMM336 carries a gene that encodes a protein with a consensus N-CHO site at residue 4 (R4N); plasmid pMM337 carries a gene that encodes a protein with an N-CHO site at residue 111 (E111N). COS7 cells were transfected with pAC265, pMM336, or pMM337, and cytoplasmic extracts were prepared 40 h later. Each extract was subsequently incubated for 2 h at 37°C in the presence or absence of a mixed preparation of endoglycosidase F and N-glycosidase F (endo F; Boehringer Mannheim) and electrophoresed on an SDS-polyacrylamide gel. A Western blot was probed with LSU32 (Fig. 4) . The R4N mutant (lanes 3 and 4) was identical to the wild type (lanes 1 and 2) and therefore was not glycosylated. In contrast, the E111N mutant (lane 5) had an additional band of lower mobility than that of nonglycosylated UL45-2. Incubation of the extract with endo F resulted in the disappearance of this band (lane 6), confirming that it represents glycosylated UL45-2. Even though the majority of the mutant protein was not glycosylated, presumably because glycosylation at this site is inefficient, the observation that glycosylation occurred on the C-terminal side of the membrane anchor but not on the Nterminal side indicates that the C-terminal side is present in the lumen of the endoplasmic reticulum (ER), defining UL45-2 as a type II membrane protein.
The cellular location of UL45-2 was examined by immunofluorescence analysis of COS7 cells transfected with plasmid pAC265. The cells were fixed with 3% paraformaldehyde-2% sucrose in phosphate-buffered saline; for staining of internal antigens, they were subsequently permeabilized by incubation in Dulbecco modified Eagle medium (DMEM)-5% fetal bovine serum (FBS) containing 0.5% Triton X-100 detergent and 10% sucrose. Incubation with the primary antibody (LSU32) was for 30 min at room temperature in DMEM-5% FBS. if it was present at the cell surface. The intracellular location was further investigated by cotransfection of COS7 cells with pAC265 and pXM-BiP-Tag (7a), a plasmid that expresses an epitope-tagged form of the ER-resident protein BiP. After fixation and permeabilization, the cells were stained with LSU32 and a mouse monoclonal antibody that recognizes the epitope tag (12CA5; Boehringer Mannheim), followed by goat antirabbit IgG-FITC and goat anti-mouse IgG-tetramethyl rhodamine isothiocyanate (TRITC). As shown in Fig. 5 , the patterns of staining for UL45-2 (Fig. 5A) and BiP (Fig. 5B) were very similar, indicating that UL45-2 is largely if not entirely contained within the ER in transfected cells. Clearly, it would be interesting to know if UL45-2 is also retained within the ER in infected cells. Unfortunately, after blocking the viral Fc receptor with an excess of nonspecific rabbit IgG, we have not been able to detect UL45-2 in infected cells using biotinylated LSU32 and then streptavidin-FITC.
In summary, the work described in this paper is a characterization of important properties of the HSV-2 UL45 protein.
A polyclonal antibody against UL45-2 recognized the protein in infected cells and in cells transfected with an expression plasmid. UL45-2 was shown to be an integral membrane protein and was synthesized sufficiently early during infection to be involved in cell-cell fusion. Furthermore, it was found to have a type II membrane orientation, the first HSV membrane protein known to have this orientation. In transfected cells, UL45-2 is retained within the ER, but in infected cells, its location is not yet known. Future studies will address the issues of whether UL45-2 is required for HSV-2 entry into cells or for cell-cell fusion in various syncytial backgrounds and, if so, how it participates in these processes.
